Suppr超能文献

小梁网细胞是青光眼细胞治疗的宝贵资源。

Trabecular meshwork cells are a valuable resource for cellular therapy of glaucoma.

机构信息

Department of Ophthalmology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Department of Ophthalmology, the Second People's Hospital of Yunnan Province (Fourth Affiliated Hospital of Kunming Medical University), Yunnan Eye Institute, Key Laboratory of Yunnan Province for the Prevention and Treatment of Ophthalmology (2017DG008), Provincial Innovation Team for Cataract and Ocular Fundus Disease, The Second People's Hospital of Yunnan Province (2017HC010), Expert Workstation of Yao Ke (2017IC064), Kunming, China.

出版信息

J Cell Mol Med. 2019 Mar;23(3):1678-1686. doi: 10.1111/jcmm.14158. Epub 2019 Jan 18.

Abstract

Trabecular meshwork (TM) contains a subset of adult stem cells or progenitors that can be differentiated into corneal endothelial cells, adipocytes and chondrocytes, but not osteocytes or keratocytes. Accordingly, these progenitors can be utilized as a cell-based therapy to prevent blindness caused by glaucoma, corneal endothelial dysfunction and other diseases in general. In this review, we review in vitro expansion techniques for TM progenitors, discuss their phenotypic properties, and highlight their potential clinical applications in various ophthalmic diseases.

摘要

小梁网(TM)包含一组成人干细胞或祖细胞,这些细胞可分化为角膜内皮细胞、脂肪细胞和成软骨细胞,但不能分化为成骨细胞或角膜细胞。因此,这些祖细胞可以用作基于细胞的治疗方法,以预防青光眼、角膜内皮功能障碍和其他一般疾病引起的失明。在这篇综述中,我们回顾了 TM 祖细胞的体外扩增技术,讨论了它们的表型特性,并强调了它们在各种眼科疾病中的潜在临床应用。

相似文献

2
Human Trabecular Meshwork Progenitors.人眼小梁网祖细胞。
Int J Med Sci. 2019 May 10;16(5):704-710. doi: 10.7150/ijms.32089. eCollection 2019.

引用本文的文献

1
Tackling visual impairment: emerging avenues in ophthalmology.应对视力障碍:眼科学的新途径
Front Med (Lausanne). 2025 Apr 28;12:1567159. doi: 10.3389/fmed.2025.1567159. eCollection 2025.
2
Glaucoma: Current and New Therapeutic Approaches.青光眼:当前及新的治疗方法
Biomedicines. 2024 Sep 3;12(9):2000. doi: 10.3390/biomedicines12092000.
6
Newer advances in medical management of glaucoma.青光眼的医学管理新进展。
Indian J Ophthalmol. 2022 Jun;70(6):1920-1930. doi: 10.4103/ijo.IJO_2239_21.
8
Normal and glaucomatous outflow regulation.正常和青光眼性房水流出调节。
Prog Retin Eye Res. 2021 May;82:100897. doi: 10.1016/j.preteyeres.2020.100897. Epub 2020 Aug 11.
9
Human Trabecular Meshwork Progenitors.人眼小梁网祖细胞。
Int J Med Sci. 2019 May 10;16(5):704-710. doi: 10.7150/ijms.32089. eCollection 2019.

本文引用的文献

2
CRISPR-Cas9-based treatment of myocilin-associated glaucoma.基于 CRISPR-Cas9 的肌球蛋白相关青光眼治疗。
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11199-11204. doi: 10.1073/pnas.1706193114. Epub 2017 Oct 2.
5
Emerging Concepts in Glaucoma and Review of the Literature.青光眼的新观念及文献综述
Am J Med. 2016 Sep;129(9):1000.e7-1000.e13. doi: 10.1016/j.amjmed.2016.03.038. Epub 2016 Apr 26.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验